Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

FMRP recruitment of β-catenin to the translation pre-initiation complex represses translation.

Ehyai S, Miyake T, Williams D, Vinayak J, Bayfield MA, McDermott JC.

EMBO Rep. 2018 Oct 25. pii: e45536. doi: 10.15252/embr.201745536. [Epub ahead of print]

PMID:
30361391
2.

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers.

Tobin SW, Hashemi S, Dadson K, Turdi S, Ebrahimian K, Zhao J, Sweeney G, Grigull J, McDermott JC.

Sci Rep. 2017 Jun 30;7(1):4476. doi: 10.1038/s41598-017-04762-x.

3.

TGFβ-TAZ/SRF signalling regulates vascular smooth muscle cell differentiation.

Pagiatakis C, Sun D, Tobin SW, Miyake T, McDermott JC.

FEBS J. 2017 Jun;284(11):1644-1656. doi: 10.1111/febs.14070. Epub 2017 Apr 20.

4.

Fermentative production of butanol: Perspectives on synthetic biology.

Nanda S, Golemi-Kotra D, McDermott JC, Dalai AK, Gökalp I, Kozinski JA.

N Biotechnol. 2017 Jul 25;37(Pt B):210-221. doi: 10.1016/j.nbt.2017.02.006. Epub 2017 Mar 9. Review.

PMID:
28286167
5.

Regulation of Hspb7 by MEF2 and AP-1: implications for Hspb7 in muscle atrophy.

Tobin SW, Yang D, Girgis J, Farahzad A, Blais A, McDermott JC.

J Cell Sci. 2016 Nov 1;129(21):4076-4090. Epub 2016 Sep 15.

6.

A p38 Mitogen-Activated Protein Kinase-Regulated Myocyte Enhancer Factor 2-β-Catenin Interaction Enhances Canonical Wnt Signaling.

Ehyai S, Dionyssiou MG, Gordon JW, Williams D, Siu KW, McDermott JC.

Mol Cell Biol. 2015 Nov 9;36(2):330-46. doi: 10.1128/MCB.00832-15. Print 2016 Jan 15.

7.

A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cells.

Mughal W, Nguyen L, Pustylnik S, da Silva Rosa SC, Piotrowski S, Chapman D, Du M, Alli NS, Grigull J, Halayko AJ, Aliani M, Topham MK, Epand RM, Hatch GM, Pereira TJ, Kereliuk S, McDermott JC, Rampitsch C, Dolinsky VW, Gordon JW.

Cell Death Dis. 2015 Oct 29;6:e1944. doi: 10.1038/cddis.2015.306.

8.

Heart disease: recruitment of MEF2 activity by β-blockers wards off cardiomyocyte death.

Hashemi S, Wales S, Miyake T, McDermott JC.

Cell Death Dis. 2015 Oct 15;6:e1916. doi: 10.1038/cddis.2015.293. No abstract available.

9.

Percutaneous Nephrolithotomy in Patients With BMI >50: Single Surgeon Outcomes and Feasibility.

Streeper NM, Radtke AC, Penniston KL, McDermott JC, Nakada SY.

Urology. 2016 Jan;87:33-9. doi: 10.1016/j.urology.2015.06.071. Epub 2015 Oct 9.

PMID:
26456745
10.

Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.

Dadson K, Turdi S, Hashemi S, Zhao J, Polidovitch N, Beca S, Backx PH, McDermott JC, Sweeney G.

J Mol Cell Cardiol. 2015 Sep;86:102-9. doi: 10.1016/j.yjmcc.2015.06.020. Epub 2015 Jul 19.

PMID:
26196305
11.

Delayed Cardiac Tamponade following Injury during Retrieval of a Superior Vena Caval Filter.

Dalvie PS, Gutta NB, McDermott JC.

J Vasc Interv Radiol. 2015 Jun;26(6):929-31. doi: 10.1016/j.jvir.2015.01.028. Review. No abstract available.

PMID:
26003465
12.

Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers.

Hashemi S, Salma J, Wales S, McDermott JC.

Cell Death Discov. 2015 Sep 14;1:15019. doi: 10.1038/cddiscovery.2015.19. eCollection 2015.

13.

Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling.

Wales S, Hashemi S, Blais A, McDermott JC.

Nucleic Acids Res. 2014 Oct;42(18):11349-62. doi: 10.1093/nar/gku813. Epub 2014 Sep 12.

14.

Expanding endourology for biliary stone disease: the efficacy of intracorporeal lithotripsy on refractory biliary calculi.

Sninsky BC, Sehgal PD, Hinshaw JL, McDermott JC, Nakada SY.

J Endourol. 2014 Jul;28(7):877-80. doi: 10.1089/end.2014.0083. Epub 2014 Apr 11.

PMID:
24617771
15.

Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma.

Dionyssiou MG, Ehyai S, Avrutin E, Connor MK, McDermott JC.

Cell Death Dis. 2014 Feb 27;5:e1094. doi: 10.1038/cddis.2014.58.

16.

In vivo interaction proteomics reveal a novel p38 mitogen-activated protein kinase/Rack1 pathway regulating proteostasis in Drosophila muscle.

Belozerov VE, Ratkovic S, McNeill H, Hilliker AJ, McDermott JC.

Mol Cell Biol. 2014 Feb;34(3):474-84. doi: 10.1128/MCB.00824-13. Epub 2013 Nov 25.

17.

Signal-dependent fra-2 regulation in skeletal muscle reserve and satellite cells.

Alli NS, Yang EC, Miyake T, Aziz A, Collins-Hooper H, Patel K, McDermott JC.

Cell Death Dis. 2013 Jun 27;4:e692. doi: 10.1038/cddis.2013.221.

18.

Krüppel-like factor 6 (KLF6) promotes cell proliferation in skeletal myoblasts in response to TGFβ/Smad3 signaling.

Dionyssiou MG, Salma J, Bevzyuk M, Wales S, Zakharyan L, McDermott JC.

Skelet Muscle. 2013 Apr 2;3(1):7. doi: 10.1186/2044-5040-3-7.

19.

Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle.

Dionyssiou MG, Nowacki NB, Hashemi S, Zhao J, Kerr A, Tsushima RG, McDermott JC.

J Mol Cell Cardiol. 2013 Jan;54:35-44. doi: 10.1016/j.yjmcc.2012.10.013. Epub 2012 Nov 5.

PMID:
23137781
20.

High-resolution protein interaction map of the Drosophila melanogaster p38 mitogen-activated protein kinases reveals limited functional redundancy.

Belozerov VE, Lin ZY, Gingras AC, McDermott JC, Michael Siu KW.

Mol Cell Biol. 2012 Sep;32(18):3695-706. doi: 10.1128/MCB.00232-12. Epub 2012 Jul 16.

21.

Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons.

Salma J, McDermott JC.

J Neurosci. 2012 Feb 22;32(8):2790-803. doi: 10.1523/JNEUROSCI.3609-11.2012.

22.

A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.

Pagiatakis C, Gordon JW, Ehyai S, McDermott JC.

J Biol Chem. 2012 Mar 9;287(11):8361-70. doi: 10.1074/jbc.M111.286203. Epub 2012 Jan 23.

23.

A method for the direct identification of differentiating muscle cells by a fluorescent mitochondrial dye.

Miyake T, McDermott JC, Gramolini AO.

PLoS One. 2011;6(12):e28628. doi: 10.1371/journal.pone.0028628. Epub 2011 Dec 9.

24.

Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics.

Chan CY, McDermott JC, Siu KW.

Int J Proteomics. 2011;2011:329467. doi: 10.1155/2011/329467. Epub 2011 Mar 29.

25.

Identification of differentially regulated secretome components during skeletal myogenesis.

Chan CY, Masui O, Krakovska O, Belozerov VE, Voisin S, Ghanny S, Chen J, Moyez D, Zhu P, Evans KR, McDermott JC, Siu KW.

Mol Cell Proteomics. 2011 May;10(5):M110.004804. doi: 10.1074/mcp.M110.004804. Epub 2011 Feb 22.

26.

Nuclear function of Smad7 promotes myogenesis.

Miyake T, Alli NS, McDermott JC.

Mol Cell Biol. 2010 Feb;30(3):722-35. doi: 10.1128/MCB.01005-09. Epub 2009 Dec 7.

27.

Menin expression modulates mesenchymal cell commitment to the myogenic and osteogenic lineages.

Aziz A, Miyake T, Engleka KA, Epstein JA, McDermott JC.

Dev Biol. 2009 Aug 1;332(1):116-30. doi: 10.1016/j.ydbio.2009.05.555. Epub 2009 May 21.

28.

Cardiotrophin-1 maintains the undifferentiated state in skeletal myoblasts.

Miyake T, Alli NS, Aziz A, Knudson J, Fernando P, Megeney LA, McDermott JC.

J Biol Chem. 2009 Jul 17;284(29):19679-93. doi: 10.1074/jbc.M109.017319. Epub 2009 May 12.

29.

Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells.

Gordon JW, Pagiatakis C, Salma J, Du M, Andreucci JJ, Zhao J, Hou G, Perry RL, Dan Q, Courtman D, Bendeck MP, McDermott JC.

J Biol Chem. 2009 Jul 10;284(28):19027-42. doi: 10.1074/jbc.M109.000539. Epub 2009 Apr 23.

30.

Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression.

Perry RL, Yang C, Soora N, Salma J, Marback M, Naghibi L, Ilyas H, Chan J, Gordon JW, McDermott JC.

Mol Cell Biol. 2009 Jun;29(12):3355-66. doi: 10.1128/MCB.00227-08. Epub 2009 Apr 13.

31.

Hepatic neuroendocrine metastases: chemo- or bland embolization?

Pitt SC, Knuth J, Keily JM, McDermott JC, Weber SM, Chen H, Rilling WS, Quebbeman EJ, Agarwal DM, Pitt HA.

J Gastrointest Surg. 2008 Nov;12(11):1951-60. doi: 10.1007/s11605-008-0640-6. Epub 2008 Aug 16.

32.

Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D.

Du M, Perry RL, Nowacki NB, Gordon JW, Salma J, Zhao J, Aziz A, Chan J, Siu KW, McDermott JC.

Mol Cell Biol. 2008 May;28(9):2952-70. doi: 10.1128/MCB.00248-08. Epub 2008 Feb 25.

33.

18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: a radiolabeling and PET validation study.

Selwyn RG, Avila-Rodriguez MA, Converse AK, Hampel JA, Jaskowiak CJ, McDermott JC, Warner TF, Nickles RJ, Thomadsen BR.

Phys Med Biol. 2007 Dec 21;52(24):7397-408. Epub 2007 Dec 5.

PMID:
18065846
34.

Transforming growth factor-beta and myostatin signaling in skeletal muscle.

Kollias HD, McDermott JC.

J Appl Physiol (1985). 2008 Mar;104(3):579-87. Epub 2007 Nov 21. Review.

35.

Identification of secreted proteins during skeletal muscle development.

Chan XC, McDermott JC, Siu KW.

J Proteome Res. 2007 Feb;6(2):698-710.

PMID:
17269726
36.

Regulation of SOCS-3 expression by leptin and its co-localization with insulin receptor in rat skeletal muscle cells.

Eguchi M, Gillis LC, Liu Y, Lyakhovsky N, Du M, McDermott JC, Sweeney G.

Mol Cell Endocrinol. 2007 Mar 15;267(1-2):38-45. Epub 2007 Jan 16.

PMID:
17223256
37.

Metastatic neuroendocrine hepatic tumors: resection improves survival.

Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.

Arch Surg. 2006 Oct;141(10):1000-4; discussion 1005.

PMID:
17043278
38.

Smad7 promotes and enhances skeletal muscle differentiation.

Kollias HD, Perry RL, Miyake T, Aziz A, McDermott JC.

Mol Cell Biol. 2006 Aug;26(16):6248-60.

39.

Multiple reaction monitoring as a method for identifying protein posttranslational modifications.

Cox DM, Zhong F, Du M, Duchoslav E, Sakuma T, McDermott JC.

J Biomol Tech. 2005 Jun;16(2):83-90.

40.

Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway.

de Angelis L, Zhao J, Andreucci JJ, Olson EN, Cossu G, McDermott JC.

Dev Biol. 2005 Jul 1;283(1):171-9.

41.

Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A.

Cox DM, Du M, Marback M, Yang EC, Chan J, Siu KW, McDermott JC.

J Biol Chem. 2003 Apr 25;278(17):15297-303. Epub 2003 Feb 12.

42.

Tandem affinity purification of protein complexes from mammalian cells.

Cox DM, Du M, Guo X, Siu KW, McDermott JC.

Biotechniques. 2002 Aug;33(2):267-8, 270. No abstract available.

43.

Sequencing of argentinated peptides by means of matrix-assisted laser desorption/ionization tandem mass spectrometry.

Chu IK, Cox DM, Guo X, Kireeva I, Lau TC, McDermott JC, Siu KW.

Anal Chem. 2002 May 1;74(9):2072-82.

PMID:
12033309
44.

Composition and function of AP-1 transcription complexes during muscle cell differentiation.

Andreucci JJ, Grant D, Cox DM, Tomc LK, Prywes R, Goldhamer DJ, Rodrigues N, Bédard PA, McDermott JC.

J Biol Chem. 2002 May 10;277(19):16426-32. Epub 2002 Mar 4.

45.

Effect of MR angiography on the diagnosis and treatment of patients with suspected renovascular disease.

Omary RA, Henseler KP, Salem R, McDermott JC, Sproat I, Wojtowycz M, Becker BN, Acher CW, Chrisman HB, Saker MB, Grist TM.

J Vasc Interv Radiol. 2001 Oct;12(10):1179-83.

PMID:
11585884
46.

Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.

Quinn ZA, Yang CC, Wrana JL, McDermott JC.

Nucleic Acids Res. 2001 Feb 1;29(3):732-42.

47.

Cell signaling and the regulation of muscle-specific gene expression by myocyte enhancer-binding factor 2.

Cox DM, Quinn ZA, McDermott JC.

Exerc Sport Sci Rev. 2000 Jan;28(1):33-8. Review.

PMID:
11131687
48.

Ureteral injury during laparoscopy-assisted anterior lumbar fusion.

Guingrich JA, McDermott JC.

Spine (Phila Pa 1976). 2000 Jun 15;25(12):1586-8.

PMID:
10851110
49.

Peripheral vascular disease and renal transplant artery stenosis: a reappraisal of transplant renovascular disease.

Becker BN, Odorico JS, Becker YT, Leverson G, McDermott JC, Grist T, Sproat I, Heisey DM, Collins BH, D'Alessandro AM, Knechtle SJ, Pirsch JD, Sollinger HW.

Clin Transplant. 1999 Aug;13(4):349-55.

PMID:
10485378
50.

Digital cameras: a rapid and inexpensive means of transferring angiographic images to referring clinicians.

Omary RA, Salem R, Wendt G, McDermott JC.

J Vasc Interv Radiol. 1999 Jul-Aug;10(7):994-5. No abstract available.

PMID:
10435717

Supplemental Content

Loading ...
Support Center